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Summary
Androgenic anabolic steroids (AAS) are often used by 
athletes to enhance athletic performance but are strong-
ly associated with detrimental cardiovascular effects 
including sudden cardiac death. 
Hypothesis: AAS use increases myocardial susceptibility 
to ischaemia/reperfusion injury. 
Methods: Rats were trained (swimming) with or without 
intramuscular injection of nandrolone laurate (0.375 
mg/kg). Untrained rats with or without nandrolone served 
as controls. Hearts were mounted on the Langendorff 
perfusion apparatus and mechanical function was mea-
sured before and after 20-min normothermic global 
ischaemia. Myocardial tissue samples were collected 
for determination of tissue cyclic nucleotide and TNFα 
concentrations.
Results: Anabolic steroids decreased the rate pressure 
product (RPP) of the exercise-trained rat heart [34 582 
± 1 778 mmHg/min vs 28 868 ± 2 446 mmHg/min 
for  exercise-trained steroid-treated hearts (p < 0.05)]. 
Reperfusion RPP was lower in both the sedentary, 
and the exercise-trained, steroid-treated hearts than in 
their concurrent vehicle-treated controls (18 276 ± 2 026 
mmHg/min vs 12 018 ± 1 725 mmHg/min for sedentary 
steroid-treated hearts and, 21 892 ± 2 912 mmHg vs 
12 838 ± 1 536 mmHg/min for exercise-trained steroid-
treated hearts). Myocardial TNFα [267.75 ± 44.25 pg/g 
vs 190.00 ± 15.75 pg/g (p < 0.05)] and cAMP concentra-
tions [406.04 ± 18.41 pmol/g vs 235.6 ± 43.26 pmol/g
(p < 0.05)] were elevated in the steroid-treated hearts 
when compared with their untreated counterparts.
Conclusions: Supraphysiological doses of anabolic ste-
roids, whether taken during exercise training or under 
sedentary conditions increase myocardial susceptibility 
to ischaemia/reperfusion injury in our model. This 
increased susceptibility may be related to steroid-induced 
increases in the pre-ischaemic myocardial cAMP con-
centrations and/or increases in both pre-ischaemic and 
reperfusion TNFα concentrations.
Cardiovasc J South Afr 2005; 16: 21–28.  www.cvjsa.co.za
Non-therapeutic use of androgenic anabolic steroids is 
prevalent among young, competitive male and female high 
school athletes who hope to improve their exercise perform-
ance with these compounds.1 They are administered in 
supraphysiological doses to enhance the development of 
muscle mass and strength and to reduce the recovery time 
after strenuous training bouts.2,3 These doses are however 
associated with pathologic changes in numerous physiologi-
cal systems. Studies using rats have shown that supra-
physiological doses of anabolic steroids cause pathophysi-
ological myocardial hypertrophy in this model.3 In the 
mouse it has been associated with inadequate vascularisa-
tion of the hypertrophied myocardium,4 and in isolated 
rat ventricular myocytes it has been linked to increased 
apoptosis.5 When combined with exercise, anabolic steroid 
use has been shown to change exercise-induced physi-
ological cardiac hypertrophy to pathophysiological cardiac 
hypertrophy.3 In this study using the exercising rat, the 
anabolic steroid-induced changes in myocardial hypertrophy 
were associated with changes in the ratio of the left 
ventricular wall thickness to internal radius. These changes 
are thought to lead to detrimental increases in LV wall stress 
and to act as one of the stimuli for abnormal heart growth 
and development. 
The exact mediators of myocardial hypertrophy are 
diverse and vary from mechanical stimuli to circulating 
humoral factors released by the heart and peripheral organs. 
Exercise-induced cardiac hypertrophy is thought to be due 
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to increases in the pre-load (diastolic filling) on the heart,6 
while the exact mechanisms for anabolic steroid-induced 
myocardial hypertrophy are at present unknown. Recent 
studies have shown that circulating cytokines such as TNFα 
may play a role in cardiac remodeling and that anabolic 
steroids strongly stimulate leukocyte TNFα production.7,8 
The question of whether a link exists between anabolic 
steroid use, serum and myocardial TNFα concentrations and 
myocardial hypertrophy remains to be established.
Exercise training in rats has been shown to improve 
myocardial resistance to ischaemia/reperfusion injury.9-11 In 
addition, exercise-induced physiological cardiac hypertro-
phy alters the heart’s susceptibility to ischaemia and reper-
fusion and renders it more resistant to ischaemia/reperfusion 
injury in in vivo rat hearts.12 These changes were associated 
with an increased energy charge and decreased lipid peroxi-
dation during ischaemia and reperfusion in the hearts from 
these animals.12 What, however, remains unclear is whether 
anabolic steroid-induced hypertrophy alters the suscepti-
bility of the heart to ischaemia/reperfusion injury. In addi-
tion, should these hearts be more susceptible to ischaemia/
reperfusion injury, the mechanism/s that contribute to this 
phenomenon need to be elucidated. 
TNFα has been implicated in ischaemia/reperfusion 
injury. Mice devoid of myocardial TNFα (knockouts) have 
been shown to be more resistant to ischaemia/reperfusion 
injury than their wild-type counterparts and treatment of rat 
hearts with anti-murine TNFα antibody before ischaemia 
also improved reperfusion function of these hearts.13,14 
Besides cytokines, elevations in cytosolic cAMP concen-
trations during ischaemia would be expected to increase 
cytosolic calcium concentrations and exacerbate ischaemia/
reperfusion injury in this model of ischaemia and reper-
fusion.15 Interestingly, the basal myocardial cAMP concen-
trations are elevated by anabolic androgenic steroids in 
isolated rat atrial muscle and contribute to the positive 
inotropic response observed with steroid treatment.16 These 
recent findings suggest that anabolic steroids could also 
potentially promote calcium overload during ischaemia in 
the anabolic steroid-treated heart. The final question remains 
whether chronic anabolic steroid treatment alters ventricular 
myocardial cAMP concentrations, and if so, what the 
effects of this alteration are on susceptibility to ischaemia/
reperfusion injury. Several studies have also suggested 
that there is a correlation between myocardial cAMP and 
cGMP concentrations17 and that the ratio between these 
cyclic nucleotides during ischaemia may be important in 
determining the severity of ischaemia/reperfusion injury.18 
The effects of anabolic steroids on NO-cGMP pathway 
activity, as assessed by measuring myocardial cGMP con-
centrations, also remain unknown. 
In this study we set out to determine how anabolic 
steroids in the absence of, or together with an exercise train-
ing programme, would influence: (1) heart size and mechan-
ical function, (2) myocardial susceptibility to ischaemia/
reperfusion injury, and (3) myocardial TNFα, cAMP and 
cGMP concentrations. To determine the effects of chronic 
androgenic anabolic steroid administration on the heart, we 
used the chronically treated rat and the isolated rat heart 
perfusion system.
Methods
Male Long–Evans rats weighing 80–100 grams were weaned 
and used in this study. Rats had free access to standard 
laboratory chow and water and were housed at 22oC and 
40% humidity with a 12-hour day–night cycle. The project 
was approved by the ethics committee of the University 
of Stellenbosch and conforms with the ‘Guide for the care 
and use of laboratory animals’ of the National Academy of 
Sciences (NIH publication no 80-23, revised 1978).
Forty 12-week-old rats were randomly assigned to four 
experimental groups; (1) a sedentary control group, (2) a 
sedentary steroid-treated group, (3) an exercising control 
group, and, (4) an exercising steroid-treated group. These 
rats were used to document the effects of anabolic steroids 
on heart size and function. An additional group of 50 rats 
was randomly divided into two groups, for the collection 
of myocardial tissue samples. One group served as the 
control, and the other as an anabolic steroid-treated group. 
Myocardial tissue samples were collected at the end of 
the pre-ischaemic perfusion period, 10 and 20 min into 
ischaemia, and at the end of reperfusion. These samples 
were used to determine myocardial TNFα and cyclic 
nucleotide concentrations. 
Training programme used during study
Rats were subjected to swimming training in baths kept 
at 30–32oC. The training programme consisted of six 
swimming sessions per week for six weeks and would be 
considered endurance-type exercise. Rats were started off 
swimming 5 min/day for the first week, then the duration 
of swimming sessions was increased by 10-min increments 
each week. By the sixth week of the training programme, 
rats swam 55 min/day, for six days per week.
Anabolic steroid administration
Nandrolone laurate (Laurabolin 25, Intervet, SA) was 
diluted in sterile peanut butter oil and injected intramuscu-
larly at a dose of 0.375 mg/kg body weight into the hind 
limb as previously described.19 Intramuscular injections 
were repeated once weekly for the six weeks of training 
and the dosage was chosen as it had been shown to induce 
cardiac growth in rats in a previous study.19 The volume of 
peanut butter oil and steroid injected varied between 10 and 
50 µl depending on rat weight. Control animals received the 
same volume of peanut butter oil intramuscularly. 
Isolation of hearts and perfusion on the 
Langendorff perfusion apparatus
Rats were anaesthetised by intraperitoneal injection of 
pento barbital (30 mg/rat). The hearts were excised and 
placed in ice-cold Krebs-Henseleit buffer before being 
mounted on a Langendorff perfusion apparatus for perfu-
sion at 37oC with Krebs-Henseleit buffer at constant pressure 
(100 cmH2O). The buffer was equilibrated with 95% CO2/5% 
O2 and had the following composition (mM) NaCl 118.0, 
KCl 4.7, MgSO4 1.2, CaCl2 1.25, NaHCO3 25, KH2PO4
1.2, and glucose 10.0. Retrograde perfusion was resumed 
within 45 s of excision of the heart. A ‘cling film’ balloon 
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was inserted into the left ventricle and attached to a pres-
sure transducer and PowerLab data recording system (AD 
Instruments, Australia).20 Cardiac parameters were recorded 
continuously and included heart rate, left ventricular devel-
oped pressure and coronary flow rates. Heart temperature 
was monitored throughout the experiment using an elec-
tronic temperature probe. 
Perfusion protocol
Hearts were equilibrated and baseline haemodynamic para-
meters [heart rate (HR), left ventricular developed pressure 
(LVDevP) and coronary flow rates (CF)] were determined 
(for 30 min). Hearts were subjected to 20 min total global 
ischaemia at 37oC. Hearts were reperfused with 1% ligno-
caine hydrochloride monohydrate for the first two min 
to reduce the incidence of reperfusion ventricular fibrilla-
tion. For the remaining 28 min of reperfusion a standard 
Krebs-Henseleit buffer was used. Heart function was again 
determined during reperfusion.
Biochemical analysis
For biochemical determinations, two groups of hearts (con-
trol and anabolic steroid-treated hearts) were freeze-clamped: 
(1) immediately before ischaemia, (2) 10 min after the onset 
of ischaemia, (3) at the end of ischaemia and, (4) at 30-min 
reperfusion. Samples were stored in liquid nitrogen until 
assays were performed.
Cyclic nucleotide determinations
The cAMP and cGMP concentrations were determined 
using radio-immunoassay kits obtained from Amersham, 
UK. For cGMP assays, freeze-clamped hearts were freeze-
dried and 10−15 mg of dry tissue was extracted in 5% 
TCA. The extracted sample was ether-washed three times 
for 5-min wash cycles. These samples were acetylated and 
then diluted 1:8 for the 125I cGMP assay. The IC50 for the 
cGMP assay was 20−25 fmol/tube.21 For the cAMP assays, 
10−15 mg freeze-dried samples were extracted with PCA, 
neutralised with KOH and assayed with the appropriate RIA 
assay. The IC50 for this assay was 1.91 pmol/tube.
21
Myocardial TNFa determinations
Myocardial TNFα content was determined using the enzyme-
linked immunosorbent assay (OptEIA rat TNFα ELISA 
kit, PharMingen, USA). Lysates were prepared according to 
Meldrum and co-workers and 100 µl of sample (containing 
equal amounts of protein) was used in each well of a 
96-well plate.22 The lower detection limit for the assay is 
13 pg/gram ww.
Calculations and statistical methods
Results were expressed as mean and SEM. Recovery of 
function: rate pressure product (RPP) during reperfusion is 
expressed as a percentage of its pre-ischaemic value.
RPP = left ventricular developed pressure (LVDevP) × heart 
rate (HR).
% RPP recovery = Reperfusion RPP (10, 20, 30 min) ×100 
 Pre-ischaemic RPP (30 min)
The unpaired Student’s t-test was used to determine 
statistical significance in the biochemical and biological data 
where only two groups of data were compared. For multiple 
comparisons, where four study groups were compared with 
each other, the ANOVA followed by the Bonferroni correc-
tion for multiple comparisons were applied. A value of p < 
0.05 was considered significant.
Results
Effects of exercise training and/or anabolic 
steroids on body and heart weight
There were no differences in body weight when comparing 
rats from the four groups before and after the training 
programme and/or anabolic steroid administration for six 
weeks. Rat weights after the training programme were 310.3 
± 10.8 g for sedentary control rats, 298.3 ± 8.6 g for 
sedentary steroid-treated rats, 300.3 ± 13.2 g for exercising 
control rats and 294.1 ± 16.3 g for exercising steroid-treated 
rats. Heart weight-to-body weight ratios were different when 
comparing the sedentary steroid- and the exercising steroid-
treated groups [4.00 ± 0.19 mg/g and 4.68 ± 0.13 mg/g, 
respectively (p < 0.05)] (Fig. 1).
Myocardial haemodynamic function
Pre-ischaemic coronary flow rate, heart rate and 
left ventricular developed pressure
Exercise training decreased resting heart rate compared 
with sedentary controls (241 ± 12 bpm and 282 ± 9 bpm 
respectively, p < 0.05). This exercise-induced bradycardia 
was lost when the rats were on chronic anabolic steroid treat-
ment. Pre-ischaemic coronary flow rates and left ventricular 
developed pressures were unchanged by exercise and/or the 
administration of anabolic steroids in these animals (Table I).
Reperfusion coronary flow rates, heart rate and 
left ventricular developed pressure 
Exercise improved reperfusion left ventricular developed 
pressure at 20- and 30-min reperfusion when compared with 
Fig. 1. Heart weight-to-body weight ratio for the 
sedentary control rats, the sedentary steroid-
treated rats, the exercising control rats and the 
exercise-trained steroid-treated rats. 
Sedentary control = sedentary vehicle-treated 
hearts; sedentary + steroid = sedentary steroid-
treated hearts; exercise control = exercise-trained 
vehicle-treated hearts; exercise + steroid = exer-
cise-trained steroid-treated hearts.
*p < 0.05; n = 8–10.
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the hearts from sedentary animals (89.57 ± 9.28 mmHg vs 
62.75 ± 4.27 mmHg and 91.29 ± 8.94 mmHg vs 70.37 ± 
5.21 mmHg respectively, p < 0.05). The use of anabolic 
steroids during the exercise training programme decreased 
left ventricular developed pressure at 20- and 30-min reper-
fusion when compared with the exercise-trained control 
animals (57.67 ± 9.36 mmHg vs 89.57 ± 9.28 mmHg, and 
58.89 ± 5.00 mmHg vs 91.29 ± 8.94 mmHg, p < 0.05).
Rate pressure product 
Pre-ischaemic rate pressure product values were similar 
for sedentary animals and their anabolic steroid-treated 
controls. The reperfusion rate pressure product values for 
these two groups of hearts were, however, different (18 276 
± 2 026 mmHg/min vs 12 018 ± 1 725 mmHg/min after 
30-min reperfusion, p < 0.05) 
Rate pressure product values were higher in the exercise-
trained hearts than in the exercise-trained, steroid-treated 
hearts both before ischaemia and during reperfusion. Pre-
ischaemic rate pressure product values were 34 582 ± 1 778 
mmHg/min vs 28 868 ± 2 446 mmHg/min (p < 0.05) at 
20-min perfusion and 34 582 ± 1 778 mmHg/min vs 28 868 
± 2 446 mmHg/min (p < 0.05) at 30-min perfusion. This 
difference persisted at 10-min (22 196 ± 2 904 mmHg/min 
vs 10 128 ± 1 447 mmHg/min), 20-min (21 753 ± 2 917 
mmHg/min vs 11 275 ± 1 941 mmHg/min) and 30-min
[21 892 ± 2 912 mmHg/min vs 12 838 ± 1 536 mmHg/min 
(p < 0.05)] reperfusion (Fig. 2). 
Percentage rate pressure product recoveries after 20-min 
global ischaemia (at 10-, 20- and 30-min reperfusion) were 
TABLE I. CORONARY FLOW (CF), HEART RATE (HR) AND LEFT VENTRICULAR DEVELOPED PRESSURE 
(LVDevP) FOR SEDENTARY VEHICLE-TREATED HEARTS, SEDENTARY STEROID-TREATED HEARTS, 
EXERCISE-TRAINED, VEHICLE-TREATED HEARTS AND EXERCISE-TRAINED STEROID-TREATED HEARTS.
Groups Functional parameters Pre-ischaemia Reperfusion
  30 min 20 min 30 min
Sedentary control (n = 8) CF (ml/min) 16.5 ± 0.5 15.7 ± 0.8 14.8 ± 1.1
 HR (beats/min) 282 ± 10 255 ± 17 259 ± 20
 LVDevP (mmHg) 113.7 ± 6.1 62.8 ± 4.3  70.4 ± 5.2
Sedentary + steroid (n = 9) CF (ml/min) 14.2 ± 0.7 12.9 ± 0.8 11.6 ± 0.6
 HR (beats/min) 278 ± 14 240 ± 25 216 ± 18
 LVDevP (mmHg) 111.1 ± 4.2 52.2 ± 8.8 55.9 ± 6.4
Exercise control (n = 10) CF (ml/min) 17.9 ± 0.6 16.8 ± 1.5 16.6 ± 1.8
 HR (beats/min) 241 ± 12# 239 ± 16  233 ± 20 
 LVDevP (mmHg) 128.8 ± 5.9 89.6 ± 9.3# 91.3 ± 8.9**
Exercise + steroid (n = 9) CF (ml/min) 13.9 ± 0.7 13.4 ± 1.2 12.0 ± 1.4
 HR (beats/min) 247 ± 21 215 ± 26 220 ± 19
 LVDevP (mmHg) 115.1 ± 4.1 57.7 ± 9.4* 58.9 ± 5.0*
Sedentary control = sedentary vehicle-treated hearts
Sedentary + steroid = sedentary steroid-treated hearts
Exercise control = exercise-trained vehicle-treated hearts 
Exercise + steroids = exercise-trained steroid-treated hearts
#p < 0.05 vs sedentary control; *p < 0.05 vs exercise control; **p < 0.05 vs sedentary control. 
Fig. 2. Rate pressure product before and after 
ischaemia for the sedentary control hearts, the 
 sedentary steroid-treated hearts, the exercise-
trained control hearts and the exercise-trained 
steroid-treated hearts.
rep = reperfusion; n = 8– 10; 
*p < 0.05 exercise control vs exercise + steroid
#p < 0.05 sedentary control vs sedentary steroid 
**p < 0.05 sedentary control vs exercise control.
Fig. 3. Percentage rate pressure product recovery 
for sedentary control hearts, sedentary steroid-
treated hearts, exercise-trained vehicle-treated 
hearts and exercise-trained steroid-treated hearts.
n = 8– 10;
*p < 0.05 sedentary control vs sedentary + steroid
#p < 0.05 exercise control vs exercise + steroid.
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higher for the hearts from sedentary animals than those for 
sedentary animals on the anabolic steroids (46.01 ± 5.37% 
vs 26.09 ± 4.56%, 50.90 ± 5.04% vs 36.93 ± 4.79% and 
58.01 ± 6.47% vs 39.89 ± 5.94%, p < 0.05). Similarly, 
rate pressure product recoveries at 10-, 20- and 30-min 
reperfusion were higher in exercise-trained rats than in 
the exercise-trained, steroid-treated hearts (61.12 ± 6.39%
vs 37.32 ± 5.96%, 59.04 ± 6.56% vs 39.87 ± 6.22% and 
respectively, p < 0.05) (Fig. 3).
Myocardial cyclic nucleotide and cytokine 
concentrations
Tissue cGMP concentrations: Myocardial cGMP concentra-
tions were elevated in the normoxic steroid-treated sedentary 
hearts when compared with their untreated counterparts 
(9.16 ± 0.82 pmol/g vs 7.38 ± 0.28 pmol/g, p < 0.05). 
Myocardial cGMP concentrations were also elevated in 
these steroid-treated hearts by 10-min ischaemia but returned 
to basal concentrations by 20-min ischaemia (20.81 ± 
3.46 pmol/g and 11.63 ± 2.81 pmol/g respectively). There 
was a delay in the elevation in cGMP concentrations in 
the vehicle-treated hearts. After 10-min ischaemia, cGMP 
concentrations were 9.98 ± 2.48 pmol/g and after 20-min 
ischaemia they were 20.55 ± 3.03 pmol/g. During reperfu-
sion, myocardial cGMP concentrations returned to basal con-
centrations by 30-min reperfusion in both groups (Table II).
Tissue cAMP concentrations: cAMP concentrations were 
significantly elevated under normoxic conditions (before 
ischaemia) in the steroid-treated animals when compared 
with the vehicle-treated ones (406.04 ± 18.41 pmol/g vs 
235.60 ± 43.26 pmol/g, p < 0.05). cAMP concentrations were 
similar in both groups during ischaemia and reperfusion. 
Myocardial TNFα concentrations: Myocardial TNFα con-
centrations were elevated in the normoxic hearts from 
steroid-treated sedentary animals, compared with their con-
trol (vehicle-treated) counterparts (267.75 ± 44.25 pg/g vs 
190.00 ± 15.75 pg/g, p < 0.05). During ischaemia there 
were no differences in myocardial TNFα concentrations, 
but during reperfusion, the TNFα concentrations were 
again elevated in the hearts of the steroid-treated sedentary 
animals (511.13 ± 13.37 pg/g vs 287.63 ± 59.95 pg/g for 
controls, p < 0.05) (Fig. 4). 
Discussion
The aim of the study was to determine whether anabolic 
steroid-induced pathophysiological cardiac hypertrophy (as 
opposed to exercise-induced physiological hypertrophy) 
is associated with increased myocardial susceptibility to 
ischaemia/reperfusion injury. We also wished to identify 
potential mechanisms for: (1) the anabolic steroid-induced 
cardiac hypertrophy and, (2) the differences in susceptibility 
of the steroid-treated hearts to ischaemia/reperfusion injury. 
We found that chronic use of supra-physiological doses of 
anabolic steroids: (1) decreases mechanical function of the 
heart when used in conjunction with an exercise training 
programme and, (2) decreases post-ischaemic mechanical 
function of the normal sedentary and exercise-trained heart. 
We also found that the chronic use of anabolic steroids 
increases myocardial cAMP and TNFα concentrations in 
the normoxic heart under basal conditions. 
Although there is mounting evidence to implicate ana-
bolic steroids in the development of cardiovascular abnor-
malities that could result in death, most evidence is indirect 
and is based on a limited number of clinical case studies.23-25 
Very little is known about the mechanisms for anabolic 
steroid-induced pathophysiological myocardial hypertrophy 
seen in athletes. Also, little is known about the effects of 
chronic anabolic steroid use on the susceptibility of the 
heart to ischaemia/reperfusion injury, or which changes in 
these hearts contribute to the changes in the susceptibility of 
the heart to ischaemia/reperfusion injury.
Exercise training and steroids: effects on function 
and morphology in the heart 
The effects of chronic anabolic steroid use on the exercise-
trained and the sedentary heart are not well understood. 
Although there is evidence to suggest that TNFα may con-
Fig. 4. Myocardial TNFα concentrations for the 
sedentary control rats and the sedentary steroid-
treated rats.
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TABLE II. MYOCARDIAL cAMP AND cGMP CONCENTRATIONS (PMOL/G WW) BEFORE, DURING AND 
AFTER ISCHAEMIA FOR HEARTS FROM SEDENTARY CONTROL RATS AND SEDENTARY ANABOLIC
STEROID-TREATED RATS.
   Pre-ischaemia 10-min  ischaemia 20-min ischaemia 30-min reperfusion
Sedentary control cAMP 235.60 ± 43.26 343.12 ± 17.04 339.32 ± 50.61 235.83 ± 36.03
 cGMP 7.38 ± 0.28 9.98 ± 2.47 20.55 ± 3.03 4.49 ± 0.33
Sedentary + steroid cAMP 406.04 ± 18.41* 289.53 ± 44.18 300.36 ± 17.66 193.66 ± 29.38
 cGMP 9.16 ± 0.81* 20.81 ± 3.46* 11.63 ± 2.81* 8.14 ± 2.24
*p < 0.05 vs sedentary + steroid group; n = 4–6.
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tribute to myocardial remodeling,7 and we did see increases 
in myocardial TNFα concentrations in the normoxic steroid-
treated hearts, we have no direct evidence to suggest that
these elevations played a causative role in the myocardial 
hypertrophy in our study. 
Chronic anabolic steroid use suppresses basal mechanical 
function and contractile reserve capacity of the normal 
untrained heart.20-22 In contrast with these adverse effects, 
exercise training is known to increase the contractile reserve 
capacity of the heart.29,30 The unresolved question is what 
the combination of exercise and anabolic steroids does 
to the function of the heart. Some studies suggest that 
anabolic steroids compromise both the contractile reserve 
capacity and the basal work capacity of the exercise-trained 
heart.27,31 
The exercise-trained rat hearts in our study had basal 
RPP values similar to those of their untrained counterparts 
(Fig. 2). The contractile reserve capacity of the hearts was, 
however, not tested in this study. In our study, we chose 
not to challenge the hearts with positive inotropes before 
ischaemia, as these interventions may also affect the severity 
of ischaemia/reperfusion injury in these hearts. We did 
not find any differences between the basal pre-ischaemic 
function of the hearts from sedentary animals and their 
sedentary steroid-treated counterparts. This lack of effect 
of anabolic steroids in sedentary animals may be related 
to the dose of the steroid we used. In the studies where 
mechanical function of the hearts was suppressed, the doses 
were 100-fold26 and 50-fold28 higher. We did, however, find 
that the hearts from animals that were on the training 
programme developed higher RPP than their anabolic 
steroid-treated counterparts. These data support the findings 
of Liang and co-workers who found that anabolic steroids 
only attenuated mechanical function of hearts subjected to 
an exercise training programme.31 
LeGros and co-workers proposed that the anabolic ster-
oid-induced decrease in myocardial function observed in 
their study on untrained rats may be attributed to structural 
changes, possibly in collagen cross-link formation.28 They 
proposed that this could lead to a decreased left ventricular 
compliance and consequent decreased stroke volume in 
these animals.
The exact myocardial cellular changes that occur when 
combining exercise training with anabolic steroid use is not 
well defined. Besides possible changes in collagen cross-
link formation,28 anabolic steroids evidently change collagen 
synthesis and distribution in the left ventricle.32 It has
also been shown that anabolic steroids may prevent the 
exercise-induced increase in LV wall thickness to internal 
diameter ratio.3 This change may cause an increase in the 
LV wall stress in the anabolic steroid-treated heart and 
contribute to the decreased cardiac performance seen in 
these hypertrophied hearts.31 We found that in our model 
the use of anabolic steroids combined with exercise training 
decreased mechanical function of the normoxic heart (Fig. 
2). These data support the work reported by Liang and 
co-workers that showed that hearts from rats trained on a 
treadmill and treated with nandrolone decanoate performed 
poorly when compared with their trained, vehicle-treated 
counterparts.31 
Exercise training, anabolic steroids and myocardial
susceptibility to ischaemia/reperfusion injury 
The reduced susceptibility of the exercise-induced hyper-
trophied heart to ischaemia/reperfusion injury is well docu-
mented.9,10,12 In our study, exercise-trained rats were also 
more resistant to ischaemia/reperfusion injury, as reflected 
by the better absolute RPP values (Fig. 2) and RPP percent-
age recoveries (Fig. 3) seen in these hearts.
The effects of anabolic steroid treatment combined 
with exercise training on the susceptibility of the heart to 
ischaemia and reperfusion injury is, however, unresolved. 
Our data suggest that the chronic use of supra-physiological 
doses of anabolic steroids, whether used in sedentary 
animals or in animals subjected to an exercise training 
programme increases the susceptibility of the heart to 
ischaemia/reperfusion injury (Fig. 3). These hearts had 
poorer reperfusion mechanical function when compared 
with hearts from untreated animals (Figs 2, 3). Clinical 
case studies abound that implicate anabolic steroid use in 
myocardial infarction and sudden cardiac death (SCD).33-36 
What remains unclear is whether these increases in the 
incidence of SCD are directly related to the effects of 
steroids on the myocardium, or are due to the vascular 
effects of these steroids. 
Chronic anabolic steroid use has been shown in primates 
to alter serum lipid profiles by decreasing HDL-C.37 These 
changes would increase the animal’s risk for coronary heart 
disease. Although we did not investigate the effects of the 
anabolic steroids on vascular morphology in our rats, we 
found that the coronary flow rates of all hearts perfused 
on the perfusion apparatus were similar (Table II). These 
data would suggest that the function and morphology of the 
coronary vasculature in all our rats was similar and would 
therefore not contribute to the differences in function and 
post-ischaemic recovery observed in this study.
Effects of anabolic steroids on myocardial cyclic 
nucleotide and cytokine concentrations
We wished to determine whether anabolic steroid use altered 
myocardial cyclic nucleotide concentrations and whether 
there was a change in myocardial cytokine and stress-
activated protein kinase activity associated with anabolic 
steroid use. 
A recent study has shown that chronic anabolic steroid 
treatment attenuates beta-adrenoceptor-mediated contractile 
response in the rat heart.38 Also, Velasco and co-workers 
found that the positive inotropic response induced by andro-
gens in the isolated rat atrium was associated with elevated 
tissue cAMP concentrations.16 We found that chronic ana-
bolic steroid use caused an elevation in basal cAMP 
concentrations in the normoxic heart before ischaemia. This 
chronic increase in the cAMP concentrations was, however, 
not associated with an increase in mechanical function of 
these anabolic steroid-treated hearts (see Fig. 2). Contrary to 
expectations, the anabolic steroid-treated hearts performed 
poorly when compared with their concurrent untreated 
counterparts, despite the approximately 73% increase in 
cAMP concentrations seen in these hearts. Anabolic ste-
roid-treated hearts are thought to have structural abnormali-
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ties such as increased or abnormal collagen distribution. 
Indications are that these abnormalities adversely affect 
systolic and diastolic function of the heart. The possibility 
exists that the elevated beta-adrenoceptor−cAMP pathway 
activity seen in these steroid-treated hearts is simply not
adequate to overcome the restrictions placed on the heart by 
the abnormal collagen distribution and structure. 
Increases in the concentrations of myocardial cAMP 
would in turn be expected to increase cytosolic calcium con-
centrations in these hearts. We and others have shown that 
elevated cytosolic calcium concentrations during ischaemia 
and early reperfusion increase the severity of ischaemia/
reperfusion injury in the rat heart.15,39,40 The elevated cAMP 
concentrations in these anabolic steroid-treated hearts could 
potentially exacerbate myocardial calcium overload during 
early ischaemia and worsen ischaemia/reperfusion injury. 
Although myocardial cAMP concentrations were similar in 
the steroid-treated and untreated hearts during ischaemia, the 
elevated cAMP (and presumably calcium) concentrations 
in the steroid-treated hearts before ischaemia may set the 
stage for more severe calcium overload during ischaemia 
in these hearts. 
Myocardial cGMP concentrations were moderately ele-
vated in the normoxic steroid-treated hearts but rose sharply 
early in ischaemia when compared with untreated animals. 
These small differences in cGMP concentrations (relative 
to the cAMP changes) before and during ischaemia appear 
to have had little or no effect on the severity of ischaemia/
reperfusion injury.
The anabolic steroid-induced elevation in myocardial 
cyclic nucleotide concentrations could be due to stimulatory 
effects on myocardial guanylyl and adenyl cyclase or to 
suppressor effects on the myocardial phosphodiesterases 
responsible for the breakdown of these cyclic nucleotides. 
The exact mechanism responsible for this effect of anabolic 
steroids on the cyclic nucleotide concentrations is currently 
unknown. Similarly, no information is available on the cross-
talk between signaling pathways under these conditions.
Several studies have shown that elevated myocardial 
TNFα concentrations may increase the severity of ischaemia/
reperfusion injury. Gurevitch and co-workers have shown 
that treating the rat heart with anti-TNFα antibodies before 
ischaemia, decreases the severity of ischaemic injury and 
improves functional recovery of the heart.14 In similar stud-
ies, it has been shown that TNFα knockout mice are less 
susceptible to ischaemia/reperfusion injury than their wild-
type counterparts.13 These data suggest that the elevated 
cytokine concentrations during ischaemia may contribute to 
ischaemia/reperfusion injury. In our study, TNFα concentra-
tions were elevated in the non-ischaemic steroid-treated 
hearts. There were, however, no differences in TNFα 
concentrations when comparing the treated and untreated 
groups during ischaemia. Our data would suggest that TNFα 
played no role in determining the severity of ischaemic 
injury in our model. TNFα concentrations were again 
elevated during reperfusion in the anabolic steroid-treated 
animals and it remains to be seen whether this elevation 
in TNFα during reperfusion contributed to the decreased 
reperfusion mechanical function seen in these steroid-treated 
hearts.
Limitations of study
Although we studied mechanical function before and after 
ischaemia in both the trained and untrained rat treated 
with vehicle or anabolic steroids, we only investigated the 
biochemical effects of anabolic steroids on the hearts of 
sedentary animals. However, the data clearly indicate that 
it would be worthwhile for future studies to be performed 
to determine the biochemical effects of anabolic steroids in 
exercise-trained hearts. 
The exercise training routine possibly stressed the ani-
mals and could have lead to neurohumoral responses that 
may have influenced the data. We, however, believe that 
whether we had used treadmill running or swimming for the 
exercise training programme, the animals would have been 
subjected to some degree of stress and anxiety. This is a 
factor that may influence the physiological response of the 
animals to anabolic steroid administration but is unavoidable 
in this type of study. 
Conclusions
• Chronic use of supraphysiological concentrations of 
anabolic steroids, whether taken during an exercise train-
ing programme or under sedentary conditions, increases 
myocardial susceptibility to ischaemia/reperfusion inju-
ry in our model.
• This increase in susceptibility of the steroid-treated 
heart to ischaemia/reperfusion injury may be related 
to anabolic steroid-induced increases in pre-ischaemic 
cAMP and/or pre-ischaemic and reperfusion TNFα 
concentrations in these hearts.
We thank the National Research Foundation for their financial 
support.
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